Related Experiment Video
Updated: Jan 14, 2026

In Vivo CRISPR/Cas9 Screening to Simultaneously Evaluate Gene Function in Mouse Skin and Oral Cavity
Published on: November 2, 2020
Mutant mitochondrial elongation factor G1 and combined oxidative phosphorylation deficiency
Marieke J H Coenen1, Hana Antonicka, Cristina Ugalde
1Nijmegen Center for Mitochondrial Disorders, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands.
Abstract:
Although most components of the mitochondrial translation apparatus are encoded by nuclear genes, all known molecular defects associated with impaired mitochondrial translation are due to mutations in mitochondrial DNA. We investigated two siblings with a severe defect in mitochondrial translation, reduced levels of oxidative phosphorylation complexes containing mitochondrial DNA (mtDNA)-encoded subunits, and progressive hepatoencephalopathy. We mapped the defective gene to a region on chromosome 3q containing elongation factor G1 (EFG1), which encodes a mitochondrial translation factor. Sequencing of EFG1 revealed a mutation affecting a conserved residue of the guanosine triphosphate (GTP)-binding domain. These results define a new class of gene defects underlying disorders of oxidative phosphorylation.
Related Concept Videos
07:52In Vivo CRISPR/Cas9 Screening to Simultaneously Evaluate Gene Function in Mouse Skin and Oral Cavity
08:54In vivo Application of the REMOTE-control System for the Manipulation of Endogenous Gene Expression
11:53A Protocol for Multiple Gene Knockout in Mouse Small Intestinal Organoids Using a CRISPR-concatemer
10:19Generation of Genetically Modified Mice through the Microinjection of Oocytes
13:10DNA Vector-based RNA Interference to Study Gene Function in Cancer
10:58Quantitative and Automated High-throughput Genome-wide RNAi Screens in C. elegans

